SCHEMBL13063463

SCHEMBL13063463

O=Cc1ccc(C(=O)NCCF)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.51
NR1H4 Q96RI1 1/20 0.51
ALDH1A1 P00352 4/20 0.47
TSHR P16473 2/20 0.46
CYP1A2 P05177 1/20 0.46
NFKB1 P19838 1/20 0.46
MAOB P27338 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
MEN1 O00255 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPK1 P28482 2/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19262987 0.86 TSHR (0.64) EPHX2NR1H4ALDH1A1TSHRCYP1A2
SCHEMBL1664008 0.84 POLB (0.53) EPHX2NR1H4ALDH1A1HDAC4HDAC6
SCHEMBL9995304 0.83 CYP1A2 (0.51) EPHX2NR1H4ALDH1A1TSHRCYP1A2
SCHEMBL9625733 0.82 EPHX2 (0.51) EPHX2NR1H4ALDH1A1TSHRCYP1A2
SCHEMBL10050998 0.82 KDM4E (0.57) EPHX2NR1H4ALDH1A1TSHRBLM
SCHEMBL25018799 0.81 CYP1A2 (0.54) EPHX2NR1H4ALDH1A1TSHRCYP1A2
SCHEMBL12641858 0.81 GAA (0.57) EPHX2NR1H4ALDH1A1HDAC6MAPK1
SCHEMBL2646881 0.81 CA1 (0.58) EPHX2NR1H4ALDH1A1CYP1A2MAPK1
SCHEMBL2646800 0.81 CA1 (0.58) EPHX2NR1H4ALDH1A1CYP1A2MAPK1
SCHEMBL15652257 0.81 EPHX2 (0.54) EPHX2NR1H4ALDH1A1TSHRHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010133851-A1 PREPARATION OF LABELLED COMPOUNDS ISIS INNOVATION LIMITED (GB) 2010-11-25 WO disclosed